Key Highlights

  • FIGS shares surged more than 23% in premarket trading after the healthcare apparel company reported second-quarter net revenue of $196.6 million, up 28.8% year-over-year and above consensus of $186.1 million.
  • GAAP EPS of $0.15 far exceeded the $0.07 consensus estimate, marking the company's third consecutive quarter of 25%-plus revenue growth.
  • FIGS raised its full-year 2026 revenue growth guidance to approximately 20%, up from its prior forecast of 14% to 16%, and increased its adjusted EBITDA margin guidance to 14.8% to 15%.
  • The company expanded its share repurchase authorization by $100 million to $200 million, reinforcing confidence in its execution and expansion strategy.

Revenue and Profitability Both Beat Expectations

FIGS (NYSE:FIGS) shares surged more than 23% in premarket trading after the healthcare apparel company posted second-quarter results that topped both revenue and earnings estimates. Net revenue grew 28.8% year-over-year to $196.6 million, compared with consensus of $186.1 million, marking the company's third straight quarter of 25%-plus growth. GAAP EPS of $0.15 far exceeded the $0.07 analyst estimate. Gross margin expanded 820 basis points to 75.2%, aided by tariff refunds and pricing gains, while active customers rose 13% to 3.1 million.

Company Raises Full-Year Guidance and Expands Buyback

Management raised full-year 2026 revenue growth guidance to approximately 20%, up from its prior outlook of 14% to 16%, and lifted adjusted EBITDA margin guidance to 14.8% to 15%. The company also increased its share repurchase authorization by $100 million to $200 million, with $81 million repurchased cumulatively to date under its existing program. Growth was broad-based, with scrubwear revenue up 27%, non-scrub wear up 40%, and international revenue up 67% across 85 markets.

Strategic Developments Include V Coterie Acquisition

FIGS also disclosed the acquisition of V Coterie, a jewelry and pins/charms brand for healthcare professionals, alongside continued international and community hub expansion. The company noted a supply chain disruption tied to a U.S. Customs withhold release order affecting imports from Jordan, which it said it is mitigating through alternative supplier partners and expedited air freight while maintaining its raised full-year guidance.

Conclusion

FIGS delivered one of its strongest quarters since going public, with accelerating revenue growth, expanding margins, and a meaningfully raised outlook giving investors confidence in the company's execution. While the Jordan supply chain disruption bears watching, management's decision to raise guidance despite the challenge suggests confidence that alternative sourcing arrangements will offset the impact through year-end.